Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 50964
Gene Symbol: SOST
SOST
0.080 Biomarker disease BEFREE Sclerosteosis and van Buchem disease (VBD) are two rare autosomal recessive disorders that results from osteoblast hyperactivity, in which progressive bone overgrowth leads to very dense bones, distortion of the face, and entrapment of cranial nerves. 29080811 2018
Entrez Id: 50964
Gene Symbol: SOST
SOST
0.080 AlteredExpression disease BEFREE Forced expression of human SOST from a Dmp1 promoter fragment partially rescues preosteoblast hyperproliferation and cancellous bone overgrowth in the Bmpr1a mutant mice, demonstrating functional interaction between Bmp and Wnt signaling in the cancellous bone compartment. 28607813 2017
Entrez Id: 50964
Gene Symbol: SOST
SOST
0.080 AlteredExpression disease BEFREE In addition, expression of SOST is delayed or suppressed; resulting in active WNT signaling and enhanced periosteal bone formation, and the combined outcome is generalized hyperostosis. 28973168 2017
Entrez Id: 50964
Gene Symbol: SOST
SOST
0.080 AlteredExpression disease BEFREE Lack of SOST expression is the cause for the progressive bone overgrowth disorders sclerosteosis and Van Buchem disease. 17696759 2007
Entrez Id: 50964
Gene Symbol: SOST
SOST
0.080 GeneticVariation disease BEFREE A generalized skeletal hyperostosis in two siblings caused by a novel mutation in the SOST gene. 15869924 2005
Entrez Id: 50964
Gene Symbol: SOST
SOST
0.080 Biomarker disease BEFREE Our findings suggest that SOST is an antagonist for Wnt signaling and that the loss of SOST function likely leads to the hyperactivation of Wnt signaling that underlies bone overgrowth seen in sclerosteosis patients. 15908424 2005
Entrez Id: 50964
Gene Symbol: SOST
SOST
0.080 Biomarker disease BEFREE Sclerosteosis is a member of the family of genetic craniotubular hyperostoses. 11570544 2001
Entrez Id: 50964
Gene Symbol: SOST
SOST
0.080 Biomarker disease BEFREE Sclerosteosis is an uncommon, autosomal recessive, progressive, sclerosing, bone dysplasia characterized by generalized osteosclerosis and hyperostosis of the skeleton, affecting mainly the skull and mandible. 10330353 1999